GSK-610677

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameGSK-610677
Drug Alias NameGSK-610677GSK-610677B
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP38 γ mitogen-activated protein kinase inhibitors
TargetsP38 γ mitogen-activated protein kinase
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A